Changshan Pharmaceutical: The company's heparin export business in 2026 is affected by various factors, including changes in overseas market policy environments.

NightAirdropper · 2026-04-06T14:45:14+00:00

Securities Daily Online News: On April 6, Changshan Pharmaceutical responded to investor questions on the interactive platform, stating that the company's heparin export business in 2026 will be affected by various factors such as changes in overseas market policy environment and market competition, and the final performance achievable cannot be predicted.(Editor: Ren Shibi)

NightAirdropper

2026-04-06 14:45:14

Securities Daily, April 6, Changshan Pharmaceutical answered an investor question on the interactive platform and said that the company’s 2026 heparin export business will be affected by multiple factors, including changes in the overseas market policy environment and market competition, and the performance that can ultimately be achieved cannot be predicted.

(Editor Ren Shibi)

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.